- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.S. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
478
0 new
Companies with a Value score of at least 3, ordered by Value score
478 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BLRX | US$3.88 | 10.5% | -92.2% | US$51.3m | n/a | PS0.7x | E46.5% | n/a | ||
PMVP | US$1.42 | 0% | -17.9% | US$74.5m | US$5.80 | PB0.4x | E14.8% | n/a | ||
DBCC.F | US$0.046 | -14.0% | -47.5% | US$37.5m | US$0.19 | PS0.4x | E212.5% | n/a | ||
ALPM.Y | US$9.67 | -0.6% | -11.8% | US$2.6t | US$12.84 | PS1.4x | E39.1% | 5.1% | ||
TLSI | US$5.72 | 3.4% | -38.8% | US$174.4m | US$11.44 | PS6.5x | E60.4% | n/a | ||
CRIS | US$3.10 | -1.3% | -68.5% | US$27.1m | US$21.00 | PS2.6x | E8.1% | n/a | ||
SCLX | US$0.34 | -3.8% | -80.7% | US$64.3m | US$10.65 | PS1.1x | E6.2% | n/a | ||
IMCC | US$2.18 | -1.4% | 9.7% | US$9.4m | n/a | PS0.2x | E86.6% | n/a | ||
ASRT | US$0.81 | -5.3% | 0.6% | US$76.7m | US$3.03 | PS0.6x | E64.7% | n/a | ||
ADAP | US$0.58 | 0.5% | -58.0% | US$148.0m | US$2.27 | PS0.8x | E5.2% | n/a | ||
CSPC.Y | US$2.49 | 9.1% | -22.1% | US$56.5b | US$3.57 | PE10.2x | E1.3% | 6.5% | ||
SNPH.Y | US$9.44 | 7.2% | -4.4% | US$480.5b | US$14.04 | PE17.5x | E9.0% | 2.7% | ||
NVS | US$107.31 | -0.4% | 4.4% | US$190.9b | US$113.19 | PE17.8x | E7.0% | 3.6% | ||
BTMD | US$4.78 | 4.4% | -12.9% | US$178.0m | US$9.87 | PE20.7x | E69.0% | n/a | ||
GNMS.F | US$223.10 | 7.5% | -22.4% | US$100.9b | US$309.43 | PE12.9x | E13.9% | n/a | ||
AGEN | US$3.45 | -1.4% | -74.4% | US$81.6m | US$8.00 | PS0.5x | E9.6% | n/a | ||
DSKY.F | US$21.15 | -14.5% | -37.5% | US$6.4t | US$38.48 | PE26.1x | E18.2% | 1.8% | ||
BVNR.Y | US$8.13 | -0.4% | -3.2% | US$13.5b | US$13.05 | PE12.1x | E-0.4% | n/a | ||
ESPR | US$1.85 | -1.1% | -29.7% | US$374.4m | US$6.76 | PS1.2x | E50.2% | n/a | ||
PLX | US$2.43 | -8.6% | 69.9% | US$184.1m | US$14.50 | PS3.9x | E123.8% | n/a | ||
FOLD | US$9.07 | -5.9% | -32.3% | US$2.9b | US$16.91 | PS5.1x | E52.9% | n/a | ||
HBIO | US$1.18 | -11.3% | -73.2% | US$54.1m | US$6.25 | PS0.5x | E89.4% | n/a | ||
ACB | US$5.86 | -11.5% | 80.9% | US$452.8m | US$7.24 | PE25.6x | E39.1% | n/a | ||
PFE | US$25.90 | 1.0% | -6.0% | US$146.7b | US$31.18 | PE18.3x | E3.6% | 6.6% |